Proactive Dose Modification

Proactive Dose Modification is a dose adjustment strategy that belongs to the class of preemptive clinical interventions, differing from reactive approaches by being systematically implemented prior to the onset of toxicity based on predictive biomarkers, pharmacokinetic data, or patient-specific risk factors to optimize therapeutic efficacy and safety.

7

Publications

256

Citations

68

Authors

45

Institutions

Publications per year

2017–2026

4

Publications

7

1–5 of 7

Authors

68

  1. HS
    Hiroyuki Sugimoto

    Nagoya University, Japan

    1 publications · 52 citations

    1

    h-index

  2. MK
    Masahiko Koike

    Nagoya University, Japan

    1 publications · 52 citations

    1

    h-index

  3. JV
    Jan Van den Brande

    Antwerp University Hospital, Belgium

    1 publications · 40 citations

    1

    h-index

  4. SJ
    Seok Jin Kim

    Sungkyunkwan University, South Korea

    1 publications · 14 citations

    1

    h-index

  5. SJ
    Stephen Johnston

    Royal Marsden NHS Foundation Trust, United Kingdom

    1 publications · 36 citations

    1

    h-index

1–5 of 68

Venues

  1. 1

    h-index

  2. Sleep Health

    1 publications · 12 citations

    1

    h-index

  3. Cancer Chemotherapy and Pharmacology

    1 publications · 52 citations

    1

    h-index

  4. Journal of Crohn s and Colitis

    JCC · 1 publications · 40 citations

    1

    h-index

  5. Supportive Care in Cancer

    1 publications · 14 citations

    1

    h-index

1–5